Potassium Chloride
Also known as: KCl, potassium salt, potassium chloride supplement
Multiple randomised, double-blind crossover or parallel trials found that oral potassium chloride at typical trial doses (about 60–120 mmol/day) can increase urinary potassium and in some trials produce small but clinically relevant reductions in systolic and diastolic blood pressure and increased natriuresis. Effects appear variable between populations and study conditions; some trials showed little or no blood pressure lowering under sodium-restricted conditions or after longer treatment durations.
Last reviewed: 2026-10-14 · 4 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Potassium chloride is an oral source of potassium used to replace or supplement dietary potassium. Randomised trials have tested daily doses in the range of about 60–120 mmol/day for effects on blood pressure and sodium handling in people with or without hypertension.
Mechanism & Function
Mechanism of Action
Oral potassium increases extracellular and renal potassium availability, which can promote natriuresis and may lower vascular smooth muscle tone. Proposed mechanisms in the clinical literature include increased renal sodium excretion, modulation of aldosterone/renin and other vasoactive mediators, and direct effects of potassium on vascular smooth muscle.
Physiological Role
Potassium is a major intracellular cation essential for cellular membrane potential, nerve and muscle function, and renal sodium handling.
Primary Pathways
Performance / Health Relevance
As an electrolyte, potassium chloride helps restore or maintain potassium balance and can influence blood pressure and fluid/electrolyte handling relevant to hydration status. It has no established role as an ergogenic agent in the provided trials.
Evidence Review
No meta-analyses or systematic reviews indexed for this ingredient yet.
Dimensions marked N/A have no indexed evidence of that class. They are shown as unavailable rather than scored.
Compare Potassium Forms
Full comparison6 potassium forms are indexed. Bioavailability, clinical evidence, and best-use cases differ meaningfully between them.
| Form | Evidence |
|---|---|
Potassium ChlorideThis page Oral potassium chloride increases urinary potassium excretion; slow‑release formulations were used in multiple trials | 55/100 |
| Potassium Citrate Highly bioavailable when dissolved. | 68/100 |
| Dietary Nitrate (Potassium Nitrate) Enterosalivary reduction (oral bacteria) is required for bioconversion to nitrite; use of antibacterial mouthwash can blunt the effect | 67/100 |
| Iodine Iodide salts and iodised oil were used in trials; urinary iodine increases reliably after supplementation. | 59/100 |
| Dipotassium Phosphate High intestinal absorption. | 58/100 |
| Potassium Bicarbonate Potassium salts are generally well absorbed orally. | 53/100 |
Practical Use & Dosage
- Minimum Effective Dose
- 60 mmol/day (used in several RCTs)
- Optimal Range
- 60–120 mmol/day as used in trials
- Upper / Caution Level
- Not established from these abstracts; higher doses risk hyperkalaemia in susceptible patients
- Timing
- Daily dosing was used in trials; timing relative to meals was not specified in abstracts
- Best Format
- Slow‑release oral tablets (used in several trials)
- Bioavailability
- Oral potassium chloride increases urinary potassium excretion; slow‑release formulations were used in multiple trials
- Absorption Considerations
- Renal function and concomitant medications affect potassium handling and risk of accumulation
Safety & Interactions
Side Effects
- •Potential for elevated serum potassium (hyperkalaemia) in susceptible individuals
- •Gastrointestinal discomfort possible with oral salts (not specifically reported in the provided abstracts)
Contraindications
- Severe renal impairment (due to risk of hyperkalaemia)
- Conditions or drugs that predispose to hyperkalaemia
Drug Interactions
- •Concomitant use with potassium‑sparing diuretics, ACE inhibitors, ARBs, or other agents that raise serum potassium may increase hyperkalaemia risk (not specifically tested in these abstracts)
Who Should Avoid
- •People with known hyperkalaemia
- •People with substantially reduced renal function unless supervised by a clinician
Monitoring
Monitor serum potassium and renal function when using supplemental potassium chloride, especially in people on medications that affect potassium or with reduced renal function.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Potassium Chloride typically used or indicated?
Potassium Chloride is most commonly used for: Replenishing potassium losses, Electrolyte/hydration support, Adjunctive therapy for blood pressure management. Potassium is a major intracellular cation essential for cellular membrane potential, nerve and muscle function, and renal sodium handling.
How does Potassium Chloride work?
Oral potassium increases extracellular and renal potassium availability, which can promote natriuresis and may lower vascular smooth muscle tone. Proposed mechanisms in the clinical literature include increased renal sodium excretion, modulation of aldosterone/renin and other vasoactive mediators, and direct effects of potassium on vascular smooth muscle.
What is the recommended dose of Potassium Chloride?
The optimal range is 60–120 mmol/day as used in trials. with a minimum effective dose of 60 mmol/day (used in several RCTs). Best taken: Daily dosing was used in trials; timing relative to meals was not specified in abstracts. Upper / caution level: Not established from these abstracts; higher doses risk hyperkalaemia in susceptible patients.
What are the side effects of Potassium Chloride?
Reported side effects include: Potential for elevated serum potassium (hyperkalaemia) in susceptible individuals; and Gastrointestinal discomfort possible with oral salts (not specifically reported in the provided abstracts). Monitoring: Monitor serum potassium and renal function when using supplemental potassium chloride, especially in people on medications that affect potassium or with reduced renal function.
Does Potassium Chloride interact with medications?
Known or theoretical interactions: Concomitant use with potassium‑sparing diuretics, ACE inhibitors, ARBs, or other agents that raise serum potassium may increase hyperkalaemia risk (not specifically tested in these abstracts). Always check with a clinician before combining with prescription medication.
Who should avoid Potassium Chloride?
Potassium Chloride is generally not recommended for: People with known hyperkalaemia; People with substantially reduced renal function unless supervised by a clinician; Severe renal impairment (due to risk of hyperkalaemia); and Conditions or drugs that predispose to hyperkalaemia.
How strong is the evidence for Potassium Chloride?
Evidence level: Moderate (overall score 55/100), based on 4 indexed studies on SuppIndex.
Research & References (4)
Moderate potassium chloride supplementation in essential hypertension: is it additive to moderate sodium restriction?
Double‑blind randomised crossover in 20 patients with mild–moderate essential hypertension on moderate sodium restriction compared one month of slow‑release potassium chloride (64 mmol/day) versus placebo. Urinary potassium rose markedly with supplementation but there was no significant change in supine or standing systolic or diastolic blood pressure compared with placebo.
Does increasing potassium intake lower blood pressure in essential hypertension?
Randomised crossover trial in 23 patients with mild–moderate essential hypertension comparing one month slow‑release potassium (64 mmol/day) versus placebo without changing dietary sodium; a separate metabolic study used 98 mmol/day in 12 patients. By week 4 mean supine blood pressure fell by about 4% with potassium versus placebo. In the metabolic study potassium increased natriuresis (average cumulative sodium loss ~110 mmol) without rise in plasma renin activity.
Potassium chloride lowers blood pressure and causes natriuresis in older patients with hypertension.
Randomised double‑blind crossover in 22 patients aged ≥60 on an isocaloric controlled diet (200 mmol Na+/day, 70 mmol K+ baseline) treated with potassium chloride (120 mmol/day) or placebo for 4 days then crossed over. Systolic BP decreased by 8.6 mm Hg and diastolic by 4.0 mm Hg during potassium treatment; urinary sodium excretion increased during potassium treatment.
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group.
Randomised, double‑blind, placebo‑controlled trial (TOHP phase I) of oral potassium chloride 60 mmol/day versus placebo in 353 men and women with high‑normal diastolic BP. Urinary potassium increased significantly with active treatment. At 3 months there was a small reduction in diastolic BP (~1.8 mm Hg) versus placebo, but by 6 months the treatment effect had essentially disappeared. There was no significant effect on systolic BP at either visit. A dose‑response relationship between change in urinary potassium and change in diastolic BP was observed across quartiles.
Related Ingredients
Other top-rated ingredients in Hydration Ingredients.
Oral Rehydration Salts
75/100Randomized trials in healthy adults show ORS reduces urine output and increases short-term fluid retention compared with plain water, and promotes greater post-exercise rehydration than water; systematic reviews of treatments for acute diarrhoea list ORS among studied interventions. Evidence supports ORS for short-term replacement of fluid and electrolytes in these contexts.
Sodium Citrate
65/100A tribasic sodium salt of citric acid functioning as both an electrolyte source and systemic alkalizing agent that increases blood bicarbonate concentration and extracellular buffering capacity.
Pink Himalayan Salt
60/100~98% NaCl with trace iron oxide imparting pink colour; trace minerals are too low to be nutritionally significant but salt provides 590 mg sodium/g.
Research Overview
Moderate EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/potassium-chloride
SuppIndex. (2026). Potassium Chloride: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/potassium-chloride
Based on 4 indexed studies · Evidence level: Moderate.
Goal Ratings
Stack Compatibility
Can be combined with other electrolyte supplements but monitor total potassium intake and interactions with agents that affect potassium handling.